1. Leptin hormone level in serum of opticospinal, neuromyelitisoptica and multiple sclerosis patients
- Author
-
Sayyed Hamid Zarkesh-Esfahani, Masoud Etemadifar, Alexa Triot, Majid Bouzari, Amir H. Maghzi, Mohammad Taghi Kardi, Maryam Mostajeran, and Ehsan Bahrami
- Subjects
medicine.medical_specialty ,Expanded Disability Status Scale ,Neuromyelitis optica ,business.industry ,Multiple sclerosis ,Leptin ,medicine.medical_treatment ,digestive, oral, and skin physiology ,Immunology ,Central nervous system ,Neuroscience (miscellaneous) ,medicine.disease ,Pathogenesis ,Endocrinology ,Cytokine ,medicine.anatomical_structure ,Immunology and Microbiology (miscellaneous) ,Internal medicine ,Medicine ,Neurology (clinical) ,business ,hormones, hormone substitutes, and hormone antagonists ,Hormone - Abstract
Objectives A growing body of evidence shows that leptin acts as a pro-inflammatory cytokine in autoimmune disorders and is related to multiple sclerosis (MS) pathogenesis. The present study was an analysis of serum leptin levels among healthy volunteers and patients with different subtypes of MS, opticospinal MS (OSMS) and neuromyelitis optica (NMO). Methods Leptin concentrations in the sera of 121 healthy volunteers and 201 patients with different subtypes of MS, as well as in 27 NMO and 27 OSMS, were measured. Results Significant differences in leptin serum levels were observed between healthy volunteers, and MS, OSMS and NMO patients (P
- Published
- 2014
- Full Text
- View/download PDF